Purpose: Decorin is a small chondroitin sulfate proteoglycan that inhibits vascular endothelial cell migration and tube formation. Membrane type 1-matrix metalloproteinase (MT1-MMP) has been shown to be an important angiogenic enzyme in the cornea. We evaluated the specific role of MT1-MMP in decorin cleavage in the cornea.
T he corneal stroma contains 2 major classes of proteoglycans, keratan sulfate proteoglycans and chondroitin/ dermatan sulfate proteoglycans. [1] [2] [3] [4] Corneal keratan sulfate proteoglycans, such as lumican, decorin, and keratocan, play an important role in corneal morphogenesis by modulating collagen fibrillogenesis. Decorin belongs to a growing family of structurally related proteoglycans known as small leucinerich proteoglycans and is a normal constituent of the corneal stroma. 5 Decorin was reported to inhibit vascular endothelial cell migration and tube formation when endothelial cells were grown on decorin-coated surfaces. 6 Therefore, decorin is predicted to inhibit corneal neovascularization under normal conditions, consequently maintaining corneal avascularity. In contrast, decorin plays an important role in angiogenesis, with blood vessel growth significantly reduced in decorin knockout mice compared with wild-type mice. 7 However, the mechanism underlying the pro-and antiangiogenic effects of decorin is not well understood.
The matrix metalloproteinases (MMPs) can be classified into 2 subfamilies based on their structures: membrane type 1matrix metalloproteinases (MT1-MMPs) and secreted MMPs. 8 The MT1-MMPs possess broad-spectrum activity against various components of the extracellular matrix (ECM) and cleave ECM components such as type I and II collagens, [8] [9] [10] fibronectin, vitronectin, laminin, fibrin, and proteoglycans. [9] [10] [11] [12] Additionally, we showed that MT1-MMP cleavage of type XVIII collagen regulates angiogenesis via the production of neostatin-and endostatin-associated molecules. 13 However, whether degradation of these ECM molecules by MT1-MMP contributes to angiogenesis or an antiangiogenic effect is currently under debate.
Previous studies from our laboratory have shown expression of MT1-MMP in corneal epithelial cells (primarily of the basal epithelium) of unwounded corneas and after keratectomy wound. 14 Additionally, the major proteoglycan of the corneal stroma was identified as decorin. In this study, we investigated the effect of MT1-MMP on decorin processing and degradation and show for the first time that the degradation of decorin by MT1-MMP affects angiogenesis.
MATERIALS AND METHODS

Decorin Cleavage Assay for Recombinant MT1-MMP
All cleavage assays were carried out in a volume of 50 mL. Recombinant mouse decorin (20 ng; R&D Systems, Inc, Minneapolis, MN) was cleaved with recombinant human MT1-MMP catalytic domain (Calbiochem; San Diego, CA). Several different buffers were tested for their influence on cleavage activity (data not shown). The most effective buffer was 60 mM Tris-HCl (pH 6.5), 150 mM NaCl, 25 mM ZnSO 4 , and 25 mM CaCl 2 , which was therefore used as the standard reaction buffer. Decorin was incubated with various concentrations of recombinant human 
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MT1-MMP (0-500 ng) at different time points (0-20 hours), with 2 concentrations of Zn 2+ and Ca 2+ (0, 25 mM) and various pH conditions (pH 5.5, 6.5, and 7.6). Cleavage was typically assessed after 20 hours with 100 ng of MT1-MMP, 25 mM Zn 2+ , and pH 6.5 unless otherwise noted. The degradation pattern of decorin was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blot analysis using an anti-decorin antibody (R&D Systems, Inc).
Animals
All animal studies were conducted in accordance with the Animal Care and Use Committee guidelines of the Massachusetts Eye and Ear Infirmary and with the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research. C57BL6 wild-type mice, 6-10 weeks of age, were used.
Cell Culture
The cells and protocols used in this study were previously approved by the Schepens Eye Research Institute Animal Care and Use Committee and confirmed to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Calf pulmonary arterial endothelial cells obtained from VEC Technologies, Inc (Rensselaer, NY) were routinely grown in specific media with fetal calf serum and antibiotics (MCDB-131 complete; VEC Technologies, Inc). Corneal epithelial cells were routinely grown in Cellgro Dulbecco's Modified Eagle's Medium (Mediatech, Inc, Herndon, VA) supplemented with 10% heat-inactivated fetal calf serum (Sigma, St Louis, MO), 100 U/mL penicillin, 100 mg/mL streptomycin, and 250 ng/mL amphotericin B (Mediatech, Inc) at 37°C/5% CO 2 . All experiments were initiated with cells in the log phase of growth and designed to be completed when cultures attained 80% confluence.
Corneal Micropocket Assay
A total of 20 mice were used for this assay, with mouse corneal micropocket assays performed as previously described. 15, 16 The mice were anesthetized using a combined ketamine and xylazine injection. Proparacaine eye drops were used for local anesthesia. Corneal micropockets were created using a modified von Graefe knife in wild-type mice. Hydron pellets (0.4 3 0.4 mm) containing 120 ng of recombinant human basic fibroblast growth factor (bFGF; R&D Systems) were implanted into the micropockets. Ofloxacin eye drops were instilled after surgery, and eyes were photographed by slit-lamp microscopy (Nikon, Tokyo, Japan) and enucleated for immunohistochemical analysis on postoperative days 1, 7, 10, and 14 and for western blot analysis on postoperative day 7.
Western Blotting
Normal corneas or corneas implanted with hydron pellets were excised on day 7. The cells were lysed with lysis buffer (150 mM NaCl, 0.25% deoxycholic acid, 1% Nonidet P-40, 50 mM Tris-HCl pH 7.6). Lysed samples were mixed with sample buffer containing b-mercaptoethanol, boiled for 2 minutes and subjected to western blot analysis. SDS-PAGE was carried out using 4%-20% Tris-glycine gradient gels (Invitrogen, Carlsbad, CA). After SDS-PAGE, proteins were transferred to a hydrophobic polyvinylidene difluoride membrane (Immobilon-P; Millipore Co., Bedford, MA). The membrane was prehybridized at room temperature (RT) for 1 hour in 13 TBST (Tris-buffered saline, 0.05% Tween 20) containing 3% bovine serum albumin (Sigma). The membrane was then incubated at RT for 1 hour in 13 TBST containing either goat anti-mouse decorin antibody (1:500; R&D Systems, Inc) or rabbit anti-MT1-MMP polyclonal antiserum (1:1000; prepared in our laboratory). The rabbit polyclonal anti-MT1-MMP antiserum (designated C14) recognizes the cytoplasmic domain (QRSLLDKV) of MT1-MMP. The membrane was shaken at RT for 30 minutes in TBST supplemented with horseradish peroxidase-conjugated rabbit anti-goat immunoglobulin G (1:20,000; Pierce, Rockford, IL) or horseradish peroxidase-conjugated donkey anti-rabbit immunoglobulin G (1:20,000; Amersham Biosciences, Buckinghamshire, United Kingdom). The membrane was thoroughly washed 
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in TBST after each incubation step. After incubation with the secondary antibody, the membrane was washed a further 3 times for 10 minutes at RT with 13 TBST. Antigen detection was achieved by incubating the membrane for 1 minute at RT with a chemiluminescent substrate (SuperSignal West Pico; Pierce) and exposing it to X-Omat Blue XB-1 film (Kodak, Inc, Rochester, NY) for 10 seconds to 30 minutes. For quantification, the films were digitally scanned and band densities were quantitatively measured using Scion Image software (version 4.0.3; Scion Corp., Frederick, MD). Band densities were expressed as a ratio to the mean band density obtained from normal mouse corneas.
Aortic Ring Assay
Aortic ring assays were performed as described by Kojima et al. 17 Briefly, aortas were obtained from wild-type mice, and fatty tissues around the aorta were carefully removed with the aid of a surgical microscope. An aortic ring (1 mm length) was cut and rinsed in 5 consecutive washes of endothelial basal medium (EBM; Cambrex, Walkersville, MD). Plates (48 well) were coated with 150 mL of rat tail type I collagen gel (BD Biosciences, Bedford, MA) and incubated at 37°C for 30 minutes. An aortic ring was placed on its side, on top of the gel, and sealed in place with an overlay (100 mL) of the same collagen. After gelling at 37°C for 1 hour, 300 mL of EBM containing 20 ng/mL decorin (Sigma) and/or 20 ng/mL recombinant human MT1-MMP was added to each well. On days 6 and 9, the gels were photographed using a phasecontrast microscope equipped with a digital spot camera (Micro Video Instruments, Avon, MA). Tube formation was analyzed by counting the number of microvessels according to reported criteria. 18 The procedure was repeated 4 times, and the average result was determined.
RESULTS
Decorin and MT1-MMP in bFGF-Induced Corneal Neovascularization
The protein levels of decorin and MT1-MMP were examined in the mouse cornea 7 days after bFGF pellet implantation. Decorin was observed to have degraded into several smaller fragments in vascularized corneas, whereas these smaller fragments were not observed in 4 normal corneas (Fig. 1) . Western blot analysis using the MT1-MMP antibody revealed strong bands in the vascularized corneas, corresponding to 58 kDa. MT1-MMP was not detected in the normal corneas ( Fig. 1 ).
Cleavage of Decorin With MT1-MMP
Decorin was incubated with MT1-MMP under various culture conditions in vitro. Western blot analysis showed that decorin was cleaved by MT1-MMP in the presence of Zn 2+ and Ca 2+ ( Fig. 2A) . These results suggest that Zn 2+ and Ca 2+ are important for the activity of this proteolytic enzyme. The kinetics of decorin proteolytic processing by MT1-MMP is regulated by the concentration of MT1-MMP (Fig. 2B) . Additionally, cleavage of decorin occurred in a pH-and incubation time-dependent manner (Figs. 2C, D) . Cleavage was observed after 1 hour, but complete cleavage of the substrate required almost 10 hours (Fig. 2C) . Decorin proteolysis by MT1-MMP proceeded at pH 5.5 and pH 6.5 and at physiological pH 7.4 (Fig. 2D ).
Inhibition of Aorta Ring Tube Formation and Reversal of Inhibition
To assess the ability of MT1-MMP to modulate in vitro angiogenesis, which is inhibited by decorin, mouse aorta rings were embedded into collagen gel maintained in EBM 
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containing MT1-MMP and/or decorin. The in vitro sprouting of microvessels was inhibited by media containing decorin ( Fig. 3) . When aorta rings were maintained in media containing MT1-MMP, microvessel outgrowth was observed.
Despite the presence of decorin, the number of microvessel tubes was dramatically increased when MT1-MMP was added to decorin-containing media (Fig. 3) . These results demonstrate that MT1-MMP can diminish the antiangiogenic effects of decorin.
DISCUSSION
Our present findings demonstrate that MT1-MMP is expressed in keratocytes, with increased levels of MT1-MMP and enhanced decorin processing (degradation) during bFGFinduced corneal neovascularization. MT1-MMP cleaved decorin in a Zn 2+ -, Ca 2+ -, pH-, and concentration-dependent manner in vitro. Purified decorin inhibited tube formation in an aorta ring assay, and addition of MT1-MMP eradicated decorin's inhibitory effects. This is the first report to show that MT1-MMP cleaves the antiangiogenic factor decorin and that it may mediate angiogenesis.
MT1-MMP is a unique member of the MMP family, in that it is activated intracellularly via a furin-dependent pathway and is a membrane-bound enzyme with full proteolytic capabilities. MT1-MMP is associated with the cleavage of ECM proteins and signaling molecules, including fibronectin, laminin, type I collagen, MMP-2 and MMP-13, tumor necrosis factor a, and connective tissue growth factor. However, these ECM proteins and signaling molecules do not possess antiangiogenic effects, suggesting that the previously reported roles of MT1-MMP in the cleavage of these molecules are not closely related to angiogenesis.
In in vivo experiments, decorin was degraded into small fragments and MT1-MMP was significantly upregulated in bFGF-induced vascularized cornea. Taken together, our in vivo and in vitro observations imply that the cleavage of decorin by MT1-MMP promotes corneal angiogenesis in vivo. Järveläinen et al 19 showed that decorin influences new vessel formation in a cutaneous wound-healing model involving decorin-deficient mice. Additionally, Grant et al 20 demonstrated that decorin suppresses tumor cell-mediated angiogenesis by inhibiting tumor-derived expression of vascular endothelial growth factor. Davies et al 21 also showed that decorin alone or in combination with thrombospondin-1 inhibited angiogenesis in vitro.
Conversely, several reports have suggested that decorin promotes rather than inhibits angiogenesis. Schonherr et al 7 
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have shown that decorin deficiency leads to impaired angiogenesis in the injured mouse cornea via a chemical cauterization model. Studies suggesting that decorin is either an inhibitor or a stimulator of angiogenesis are not necessarily contradictory, but they do indicate the molecular complexity of angiogenesis under different physiologic and pathologic conditions. Nelimarkka et al 22 reported that decorin might play a role in inflammation-associated angiogenesis because capillary endothelial cells in pyogenic granuloma, and the granulation tissue of healing dermal wounds, produced decorin. Decorin may contribute toward antiangiogenic effects under physiologic conditions, whereas the degradation of decorin by MT1-MMP may induce angiogenesis under inflammatory or pathologic conditions. In this report, we demonstrated that MT1-MMP was upregulated and decorin was degraded in bFGF-induced vascularized corneas. MT1-MMP was also shown to cleave decorin in vitro. Purified decorin inhibits vascular tube formation; however, the addition of recombinant active MT1-MMP reverses decorin's inhibitory effects. Although our data suggest a role for decorin in MT1-MMP-mediated angiogenesis pathways, other likely antiangiogenic factors may also be involved in MT1-MMP-mediated corneal neovascularization. Judging from the important roles of MT1-MMP and decorin in angiogenesis, understanding the mechanism underlying MT1-MMP/decorin signaling, and regulation in angiogenesis may provide better therapeutic interventions for the treatment of not only corneal neovascularization but also angiogenesis-related disorders, such as diabetic retinopathy and cancers.
